- News Home
13 March 2014 11:08 am ,
Vol. 343 ,
In the shadow of the crisis in Crimea, Ukrainian legislators are weighing a pair of science and education bills that...
Researchers dependent on government funding would face a flat future under the White House's $3.9 trillion budget...
Reservoirs of cells that harbor HIV DNA woven into human chromosomes have become the bane of researchers trying to cure...
Geochemists have now incorporated in their models some details of the way naturally acidic rainwater dissolves rock...
Schizophrenia is a devastating mental disorder that afflicts about 1% of the world's population at one time or another...
Surface tension is a force to be reckoned with, especially if you are small. It enables a water strider to skate along...
- 13 March 2014 11:08 am , Vol. 343 , #6176
- About Us
Appetite Hormone Weakens Bones
28 January 2000 7:00 pm
The fat-busting hormone leptin curbs the appetite and sends preteens lurching into puberty. Now comes news of a more surprising connection: osteoporosis. Researchers report in the current issue of Cell that mice lacking leptin grow stronger and thicker bones than normal. The finding could eventually lead to new therapies for osteoporosis, which plagues about 28 million Americans, mostly women.
The three best known risk factors for osteoporosis are menopause, intense athleticism, and anorexia. The bone loss seems to be spurred by a hormone imbalance: either a lack of sex steroids, or too many stress or appetite-control hormones. Mice that are bred to be leptin deficient should also be prone to bone loss, based on their similarity to human risk factors--they're sterile, stressed out, and eat as if they are starving. So geneticist Gerard Karsenty of Baylor College of Medicine in Houston, Texas, had a hunch that low leptin levels in the mutant mice would weaken bones as in osteoporosis.
But when Karsenty and his colleagues examined the bones of mice that lacked leptin or its receptor, they found that the mutant animals had up to three times the bone volume and strength of their normal counterparts. "I was flabbergasted," recalls Karsenty. By tracking bone formation with radioisotopes, the researchers traced the bone buildup to overtime work of cells called osteoblasts. Further, leptin infusions into the rodents' brains whittled away the excess bone. But leptin did not appear to be acting directly on the osteoblasts--rather, leptin appears to act on its receptor in the hypothalamus and then relay some secondary signal to the body.
"It is a very strange, unpredicted result and very intriguing," says leptin researcher Joel Elmquist of Beth Israel Deaconess Medical Center in Boston, who is stymied as to the nature of the secondary signal coming from the hypothalamus. Although leptin inhibits bone growth, there may be another compound in the brain that can stimulate the osteoblasts. Karsenty is now searching for such a stimulator, which could be the beginning of a cure for osteoporosis.